Anti-Hepatitis E Virus antibody [5F3]
Be the first to review this product! Submit a review
|
(4 Publications)
Mouse Monoclonal Hepatitis E Virus antibody. Suitable for ELISA, ICC/IF, WB and reacts with Hepatitis E virus type 3 samples. Cited in 4 publications.
View Alternative Names
HEV
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Hepatitis E Virus antibody [5F3] (AB233244)
HEV-3-infected cells were fixed with acetone-methanol (1 : 1; 20 °C) and blocked with 1% FCS, then incubated with ab233244 at 1/50 dilution for 1 h at 37°C. FITC-conjugated anti-mouse IgG at 1/100 dilution was used as the secondary antibody. Cell nuclei counterstained with DAPI (Blue).
- WB
Supplier Data
Western blot - Anti-Hepatitis E Virus antibody [5F3] (AB233244)
M - PageRuler Prestained Protein Ladder
All lanes:
Western blot - Anti-Hepatitis E Virus antibody [5F3] (ab233244) at 1/1000 dilution
Lane 1:
Rat HEV capsid protein at 0.5 µg
Lane 2:
HEV genotype 3 at 0.5 µg
Lane 3:
Human parvovirus 4 VP2 protein at 0.5 µg
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
HEV impacts liver function through its replication within hepatocytes contributing to liver inflammation and damage. The virus does not form a complex with other viral components but relies on host cell machinery for its replication cycle. Hepatitis E antibodies including anti-HEV and HEV antibodies such as 5f3 can target the virus for immune recognition and clearance with the immune response playing an important role in controlling and eliminating the infection.
Pathways
The virus integrates into the immune signaling pathways associated with viral recognition and response. HEV interacts with innate immune pathways to subvert the host's defense mechanisms. The interferon pathway is particularly significant in moderating the viral life cycle and proteins such as interferon-stimulated genes (ISGs) become upregulated in response to HEV presence. Additionally interactions with proteins within the apoptotic pathway may contribute to virus-induced cellular responses influencing both cell survival and antiviral defense.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Acta biochimica et biophysica Sinica 56:1365-1372 PubMed38877781
2024
Applications
Unspecified application
Species
Unspecified reactive species
Viruses 13: PubMed33924409
2021
Applications
ICC/IF
Species
Human
BMC veterinary research 16:95 PubMed32199460
2020
Applications
ICC/IF
Species
Unspecified reactive species
Applied microbiology and biotechnology 102:185-198 PubMed29143081
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com